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Synthesis, spectral, and structural characterizations of
imidazole oxalato molybdenum(IV/V/VI) complexes†
Quan-Liang Chen, Hong-Bin Chen, Ze-Xing Cao and Zhao-Hui Zhou*
Substitutions of trans-Na(Him)[Mo2O4(ox)2(H2O)2]·H2O (1) and trans-(Him)2[Mo2O4(ox)2(H2O)2] (2) with
imidazole result in the formation of the mixed-ligand molybdenum complexes cis-Na2[Mo2O4(ox)2-
(im)2]·4.5H2O (3), cis-K2[Mo2O4(ox)2(im)2]·3H2O (4), respectively (H2ox = oxalic acid; im = imidazole).
Further reduction of cis-K2[Mo2O4(ox)2(im)2]·3H2O (4) gives a trinuclear molybdenum(IV) complex K(Him)-
[Mo3O4(ox)3(im)3]·3H2O (5), which contains an incomplete cubane cluster [Mo
IV
3O4]
4+. Two novel trinuc-
lear mixed-valence imidazole compounds [Mo3O8(im)4](im)·H2O (6) and [Mo3O8(im)4]·H2O (7) were




center, where the [MoV2O4]
2+ unit is linked by [MoVIO4]
2− anion. The Mo–Mo bond distances in 1–7
decrease with the decrease of oxidation state of molybdenum. Solid and solution NMR spectra show that
imidazole molybdenum compounds 6–8 fully dissociate in solution, where solvated imidazole and imida-
zolium groups in 6 and 8 could be served as internal references in their solid 13C NMR spectra. Further-
more, mixed-ligand molybdenum species 3 and 4 are stable in water. Stabilities of 3 and 4 in solution
may be attributed to the strong coordination of bidentate oxalate and the formation of hydrogen bond.
Dimers 2 and 4 display quasi-reversible redox process, while trimer 6 is irreversible. Bond valence calcu-
lations for 1–8 are consistent with their oxidation states of molybdenum atoms. Calculation of the oxi-
dation state in recent structure of iron molybdenum cofactor [MoFe7S9C(R-homocit)] (FeMo-co) is 3.318.
Introduction
The coordination chemistry of molybdenum has been receiv-
ing wide attention due to the significance of molybdenum
compounds in many fields, such as biochemistry, catalysis,
medicine and material.1 Until now, a number of imidazole
molybdenum compounds supported by the other transition
metals (e.g. Zn, Ni, Cu) and flexible organic ligands have been
synthesized and characterized.2 Among them, octanuclear
anion [Mo8O26(im)2]
4− (im = imidazole) has been frequently
encountered, in which two imidazoles are centrosymmetrically
coordinated to [Mo8O26] unit in octahedral geometry. Previous
research focused mainly on imidazole with molybdenum in VI
oxidation state, we deem it is important to study the other imi-
dazole molybdenum species with lower oxidation states.
Complexation of oxalates with molybdenum are restricted
in the oxidation states of V and VI.3 Formations of different
types of oxalato molybdenum complexes depend on the pH
value of the reaction solution, countercation and the ratio of
molybdenum and ligand. In the reported oxalato molybdenum
complexes, each oxalate can take multiple coordination
manners with molybdenum atoms. For example, bidentely









5 (R = Ba, pyH), and polymeric
R2[Mo
VIO3(ox)2]·xH2O
4a,6 (R = Na, K, Rb, Cs). Oxalates coordi-
nated to molybdenum are also reported with interesting μ4
and μ8 modes, like [{MoV2O4(η2-ox)2}2(μ4-ox)]6− and
[Mo8
VO16(OMe)8(μ8-ox],2–5b,7 where dinuclear fragment
[MoV2O4]
2+ with metal–metal bond is often found in the
reduced oxalato molybdenum(V) products.
The interaction of imidazole in histidine with molybdenum
displays a monodentate coordination mode in iron
†Electronic supplementary information (ESI) available: Preparations of 1, 2 and
8; anion structures of 1, 2, 4, 7 and 8 (Fig. S1–S5); 3D or 1D supramolecular view
of 1 and 8 (Fig. S6–S8); comparison of Mo–oxalato–im of 3 with Mo–homoci-
trate–histidine of nitrogenase (Fig. S9); IR spectra (Fig. S10 and S11); UV spectra
of 1–8 (Fig. S12 and S13); solution 13C NMR spectra of imidazole and sodium
oxalate (Fig. S14 and S15); solution 1H NMR spectra of 1–4 and 6–8 (Fig. S16–
S22); solid state 13C NMR spectra of 6 and 8 (Fig. S23 and S24), and cyclic vol-
tammograms of 2, 4, 5 and 6 (Fig. S25–S28); crystal data and structural refine-
ments for 1, 2 and 8, selected bond distances for 1–8, selected hydrogen
bonding geometric data in 1–8, bond valence unit calculation for 1–8, UV spec-
tral data of 1–8, solution 1H NMR spectral data of 1–4 and 6–8, electrochemical
data for 2, 4, 5 and 6 (Tables S1–S7). CCDC 847782, 847783, 890809, 890810,
891643–891646 for 1–8. For ESI and crystallographic data in CIF or other elec-
tronic format see DOI: 10.1039/c2dt31566a
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molybdenum cofactor {FeMo-co = [MoFe7S9C(R-homocit)]}.
8
The imidazole sidechain was found to be captured by the com-
plete MoFe7S9C core in the final process of FeMo-co biosyn-
thesis.9 Compared with the previous mimic works on Mo–Fe–S
and homocitrato molybdenum complexes,10 imidazole and
histidine molybdates are less reported,2,11a–c and there is no
concern on the mixed ligand molybdenum complex of imida-
zole with the component of organic acid. Moreover, typical
Mo3O4, Mo5–7 and Mo8O26 clusters have been found recently
in Mo storage protein (MoSto) from Azotobacter vinelandii,
where imidazole Nε2 atom of histidine coordinates to Mo atom
monodentately.11d
In this paper, we make an attempt to investigate the coordi-
nation chemistry between molybdenum and imidazole, as well
as imidazole with oxalate ligand. A series of molybdenum
(VI/V/IV) imidazole, oxalate, and mixed ligand complexes are
reported. These complexes are characterized by spectral, struc-
tural analyses, and cyclic voltammetry. Their solution and
solid behaviours are investigated by NMR spectroscopy.
Experimental
Materials and instrumentation
Molybdates (99%), imidazole and oxalic acid dihydrates were
purchased from Sigma. All chemicals were analytical reagents.
Infrared spectra were recorded as Nujol mulls between KBr
plates using Nicolet 200 FT-IR spectrometer. Electronic spectra
were recorded in water on a UV 2501 spectrophotometer.
Elemental analyses were performed using EA 1110 elemental
analyzers. pH value was determined by PHB-8 digital pH
meter. Solution 1H NMR and 13C NMR spectra were recorded
on a Bruker AV 500 NMR spectrometer with D2O using DSS
(sodium 2,2-dimethyl-2-silapentane-5-sulfornate) as an
internal reference. Solid state 13C NMR spectra were recorded
on a Bruker AV 400 NMR spectrometer using cross polariz-
ation, magic angle spinning (13 KHz) and adamantane as
reference. Cyclic voltammetry measurements were carried out
on a CHI 660B electrochemical station using a conventional
three-electrode single compartment cell at room temperature
under nitrogen atmosphere. The working electrode was a
glassy carbon. A platinum plate was used as the counter elec-
trode and Hg/Hg2Cl2 as a reference electrode.
Synthesis
Preparations of cis-Na2[Mo2O4(ox)2(im)2]·4.5H2O (3) and cis-
K2[Mo2O4(ox)2(im)2]·3H2O (4). Na2MoO4·2H2O (0.48 g,
2.0 mmol), H2ox·2H2O (0.25 g, 2.0 mmol) and imidazole
(0.14 g, 2.0 mmol) were dissolved in 5 mL water. The mixture
was kept stirring for 2 h and the pH value of the mixture was
adjusted to 6.0–7.0 by 2.0 M sodium hydroxide. The solution
was transferred to a serum bottle and refluxed for 2 h at
120 °C. After cooling to room temperature, the solution was
added with hydrazine hydrochloride (0.16 g, 1.5 mmol) to give
a dark red solution. The filtrate was evaporated at room temp-
erature to give yellow crystals within three days. The crystals 3
were collected by filtration and washed with water and
ethanol. Yield: 0.28 g (81%). Anal. Found: C, 17.5; H, 2.4; N,
8.0. Calc. for C10H17Mo2N4Na2O16.5: C, 17.3; H, 2.5; N, 8.1. IR
(KBr disk, cm−1): 3504vs, 2925s, 2854s, 1713vs, 1687vs, 1500w,
1639w, 1417s, 1329w, 1290m, 1095w, 1069vs, 968vs, 945m, 799w,
718m, 658m, 619m, 498s. Solution
1H NMR (500 MHz, D2O): δH
(ppm) 8.38 (NCHNH), 7.50 (NCHCH), 7.35 (NHCHCH); solu-
tion 13C NMR (500 MHz, D2O): δC (ppm) 169.66; 168.20 (CO2),
(NCHNH) 141.08, (NCHCH) 130.25, (NHCHCH) 120.84. Prep-
aration of 4 was similar to that of 3 except that sodium molyb-
date was replaced by potassium molybdate pentahydrates, and
the amounts of imidazole and hydrazine hydrochloride were
changed to 3.0 and 2.0 mmol, respectively. Yield: 0.30 g (21%).
Anal. Found: C, 17.1; H, 2.3; N, 8.2. Calc. for
C10H14K2Mo2N4O15: C, 17.2; H, 2.0; N, 8.1. IR (KBr disk, cm
−1):
3396m, 3141m, 2953m, 2854m, 1711vs, 1687vs, 1662vs, 1547s,
1499s, 1402s, 1329w, 1286w, 1261m, 1177w, 1128w, 1101w, 1071s,
964s, 905w, 791m, 736m, 715w, 655m, 616m, 486m. Solution
1H
NMR (500 MHz, D2O): δH (ppm) 8.43 (NCHNH), 7.56
(NCHCH), 7.38 (NHCHCH); solution 13C NMR (500 MHz, D2O):
δC (ppm) 169.54; 168.22 (CO2), (NCHNH)140.93, (NCHCH)
130.17, (NHCHCH) 120.88.
Transformations of 1 to 3 and 2 to 4. trans-Na(Him)
[Mo2O4(ox)2(H2O)2]·H2O (1) (62 mg) prepared as shown in the
ESI† and imidazole (10 mg) were mixed in 2.0 mL water. The
pH value of the solution was adjusted to 6.5 by 2.0 M sodium
hydroxide. The solution was transferred to a serum bottle and
refluxed for 2 h at 120 °C. The filtrate was evaporated at room
temperature for one week to give 3. Transformation of trans-
(Him)2[Mo2O4(ox)2(H2O)2] (2) to 4 was similar to that of 1 to 3
except that sodium hydroxide was replaced by potassium
hydroxide and the amount of 2 was 60 mg. The filtrate was
evaporated at room temperature for one week to give 4.
Preparation of K(Him)[Mo3O4(ox)3(im)3]·3H2O (5). In an
anaerobic box, imidazole (0.20 g, 3.0 mmol) and H2ox·2H2O
(0.38 g, 3.0 mmol) were added to a mixture of K2MoO4·5H2O
(0.66 g, 2.0 mmol) and hydrazine hydrochloride (0.21 g,
2.0 mmol) in water (8 mL) with constant stirring. The mixture
was sealed and heated for 20 h at 70 °C. After cooling to room
temperature, the mixture was filtered. Slow evaporation at
room temperature led to red crystals of 5 for two weeks. Yield:
64 mg (10%). Anal. Found: C, 22.3; H, 2.0; N, 11.6. Calc. for
C18H23KMo3N8O19: C, 22.0; H, 2.4; N, 11.4. IR (KBr disk,
cm−1): 3431vs, 3129vs, 2952vs, 2875s, 1709vs, 1679vs, 1546w,
1501w, 1401s, 1326w, 1261m, 1145w, 1095w, 1099w, 1072s, 955w,
903w, 945m, 790s, 756m, 723w, 658w, 625w, 516w, 472m.
Transformation of 4 to 5. In an anaerobic box, compound 4
(70 mg) and hydrazine hydrochloride (50 mg) were mixed in
5 mL water with constant stirring. The pH value of the solution
was adjusted to 5.2 with the addition of dilute potassium
hydroxide. The mixture was heated for 5 h at 70 °C. Slow evap-
oration of the filtrate at room temperature gives 5.
Preparations of [Mo3O8(im)4](im)·H2O (6) and
[Mo3O8(im)4]·H2O (7). Na2MoO4·2H2O (0.48 g, 2.0 mmol) and
imidazole (0.17 g, 2.5 mmol) were dissolved in 10 mL water
with constant stirring. The solution was transferred to a serum
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bottle and refluxed for 2 h. After cooling to room temperature,
hydrazine hydrochloride (0.25 g, 2.5 mmol) was added to the
mixture to give a dark pink solution. The pH value of the sol-
ution was adjusted to 7.5 with sodium hydroxide (2.0 M). The
solution was kept in a refrigerator for one week to give deep
yellow crystals, which were filtered and washed with ethanol to
give 6. Yield: 0.33 g (63%). Anal. Found: C, 23.6; H, 2.8; N,
18.0. Calc. for C15H22Mo3N10O9: C, 23.3; H, 2.9; N, 18.1. IR
(KBr disk, cm−1): 3415vs, 3142s, 3044m, 2940m, 2855m, 1630s,
1549m, 1494w, 1445w, 1410m, 1329m, 1260m, 1135m, 1110m,
1072s, 961m, 904s, 813vs, 815vs, 765s, 718vs, 659m, 617m, 493w.
Solution 1H NMR (500 MHz, D2O): δH (ppm) 8.31 (NCHNH),
7.34 (NCHCH); solution 13C NMR (500 MHz, D2O): δC (D2O,
ppm) 137.47 (NCHNH), 123.03 (HNCHCH). Similarly,
Na2MoO4·2H2O (0.36 g, 1.5 mmol) and imidazole (0.27 g,
4.0 mmol) were dissolved in 5 mL water. The mixture was kept
stirring for 20 min and the pH value was adjusted to 7.2 by
dilute hydrochloric acid. The solution was transferred to a
serum bottle and refluxed for 2 h at 120 °C. After cooling to
room temperature, hydrazine hydrochloride (0.16 g, 1.5 mmol)
was added to the solution and stirred for 1 h. Yellow block
crystals 7 were collected within one week after filtration. Yield:
0.16 g (47%). Anal. Found: C, 20.3; H, 2.6; N, 15.8. Calc. for
C12H18Mo3N8O9: C, 20.4; H, 2.6; N, 15.9. IR (KBr disk, cm
−1):
3418vs, 3145vs, 3054vs, 2953s, 2859s, 2630w, 1631m, 1542m,
1496m, 1443m, 1419w, 1384w, 1326m, 1259m, 1175w, 1139m,
1103m, 1069vs, 969s, 955m, 905m, 856s, 808vs, 766vs, 724s, 658m,
619m, 485w. Solution
1H NMR (500 MHz, D2O): δH (ppm) 8.25
(NCHNH), 7.29 (NCHCH); solution 13C NMR (500 MHz, D2O):
δC (D2O, ppm) 137.10 (NCHNH), 123.00 (HNCHCH).
Transformation of (Him)4[Mo8O26(im)2] (8) to 6. Compound
8 (0.16 g) prepared as shown in ESI† and imidazole (10 mg)
were mixed in 2.0 mL water. The mixture was kept stirring for
2 h. Hydrazine hydrochloride (15 mg) was added to the
mixture and the pH value of the solution was adjusted to 7.5.
The solution was transferred to a serum bottle and refluxed for
2 h. After cooling to room temperature, the solution was fil-
tered and kept at room temperature for one week to give deep
yellow crystals of 6.
X-ray crystallography
Suitable single crystals of 1–8 were selected and quickly
mounted onto thin glass fibers to prevent the loss of water
molecules. X-ray intensity data for compounds 1–8 were
measured at 173 K or 123 K on an Oxford CCD diffractometer
with Mo Kα radiation (λ = 0.71073 Å). Empirical absorption
was applied to all data using SADABS and CrysAlis (multi-scan)
programs. The initial model was obtained through direct
method and the completion of the rest of the structure
achieved by difference Fourier strategies. The structures were
refined by least squares on F2, with anisotropic displacement
parameters for non-H atoms. Hydrogen atoms unambiguously
defined by the stereochemistry were placed at their calculated
positions and allowed to ride onto their host carbons both in
coordinates as well as in thermal parameters (C–H, 0.97 Å).
Those attached to oxygen atoms and needed for the H-
bonding description were located in a late Fourier map and
refined with similarity restrains [O–H, 0.85(1) Å; H⋯H, 1.39(1)
Å]. All calculations to solve and refine the structures and to
obtain derived results were carried out with SHELXS 97, and
SHELXL 97 programs. Full use of the CCDC package was also
made for searching in the CSD database.12 CCDC deposition
numbers are 847782, 847783, 890809, 890810, 891643–891646
for 1–8 respectively. Crystal data and structure refinements for
1–8 are summarized in Tables 1 and S1.† Selected bond dis-
tances for 1–8 are summarized in Table S2.†
Table 1 Crystal data and structural refinements for 3–7
Compounds 3 4 5 6 7
Chemical formula C10H17Mo2N4Na2O16.5 C10H14K2Mo2N4O15 C18H23KMo3N8O19 C15H22Mo3N10O9 C12H18Mo3N8O9
Formula mass 695.14 700.33 982.34 774.21 706.16
Crystal system Monoclinic Monoclinic Triclinic Monoclinic Monoclinic
a/Å 27.783(2) 8.6355(2) 9.5495(4) 10.4113(3) 8.2312(2)
b/Å 10.1376(4) 29.6451(9) 11.8097(5) 8.5644(3) 15.6958(4)
c/Å 18.360(1) 8.8144(3) 15.7370(8) 28.5006(9) 8.7803(2)
α/° 76.902(4)
β/° 121.619(7) 107.402(3) 73.425(4) 95.693(3) 99.098(2)
γ/° 66.739(3)
Unit cell volume/Å3 4403.4(4) 2153.2(1) 1549.6(1) 2528.8(1) 1120.10(5)
Space group C2/c P21/n P1̄ P21/n P21
Temperature (K) 173 173 123 173 173
No. of formula units per unit cell, Z 4 4 2 4 2
No. of reflections measured 11 203 10 909 15 258 6232 2909
No. of independent reflections 4713 4622 6635 4075 2354
Rint 0.0392 0.0395 0.0678 0.0437 0.0558
Final R1 values (I > 2σ(I)) 0.0358 0.0381 0.0601 0.0274 0.0445
Final wR(F2) values (I > 2σ(I)) 0.0731 0.0706 0.1045 0.0687 0.0788
Final R1 values (all data) 0.0469 0.0500 0.0921 0.0315 0.0536
Final wR(F2) values (all data) 0.0780 0.0745 0.1191 0.0707 0.0868
Goodness of fit on F2 1.034 1.067 1.053 1.043 0.747
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Syntheses and structural studies
Syntheses and transformations of imidazole molybdenum
species 1–8 were carried out in aqueous solution as shown in
Scheme 1. Preparations of the complexes mainly depend on
the requisite proportions of molybdate and ligand, counterca-
tions, pH value and the reaction temperature. In acidic sol-
ution, dinuclear complexes 1 and 2 contained
[Mo2O4(ox)2(H2O)2]
2− anions were isolated in sodium and imi-
dazolium salts as described in the ESI.† When excess imida-
zoles were added, the coordinated water molecules of trans-
[Mo2O4(ox)2(H2O)2]
2− were replaced by imidazoles in neutral or
weak acidic solution, forming mixed-ligand cis-
[Mo2O4(ox)2(im)2]
2− anions, which were isolated as sodium
and potassium salts. Further reduction of 4 by hydrazine
hydrochloride produces a trinuclear mixed-ligand molyb-
denum(IV) complex 5. Low valent compound 5 is sensitive to
oxygen and was obtained in an anaerobic condition.
Trinuclear mixed-valence imidazole complexes 6 and 7 were
obtained from a mixture of imidazole, molybdate and hydra-
zine hydrochloride in weak basic condition, which can also be
obtained by the transformation of octanuclear species 8.
Neutral [Mo3O8(im)4] units in 6 and 7 are dominant species in
solution, further reduced product was not isolated in our
experiment. It is inferred that there is a one-dimensional
chain product {[Mo2O4(im)4][MoO4]}n. However, attempts to
isolate it were unsuccessful. In synthesis, coordination of imi-
dazole is comparable with oxalato ligand in basic condition.
The coordination ability of imidazole ligand is sensitive to the
pH value of the reaction. Weak basic reaction conditions are
good for the coordination of imidazole with molybdenum,
while a low pH value in solution tends to make imidazole as
the protonated imidazole countercation. Imidazole can some-
times act as a solvated molecule as found in 6.
The structures of 1–4 contain dinuclear [MoV2O4]
2+ cores
with Mo–Mo bonds. The oxalato ligand coordinates each mol-
ybdenum atom through two carboxylate oxygens in a bidentate
chelating manner. Each molybdenum atom exists in a dis-
torted octahedral geometry defined by two O atoms of oxalate,
two bridging oxo group, one terminal oxo atom and a N atom
of imidazole or an O atom of water molecule. The position of
the pair of oxalates, imidazoles or water molecules can be
either on the same side or on opposite sides of the plane
defined by the Mo2O4 unit. The trans arrangement was
observed for 1 and 2 (Fig. S1 and S2†), while the cis arrange-
ment was found for 3 and 4 [Fig. 1 (left) and S3†]. In 1–4, one
of the two coordinated oxalato oxygen atoms is trans to the
MovO group, while the other is trans to the bridging atoms.
The trans influence of the terminal oxo group is reflected in
the difference of the two Mo–Oox bond lengths [e.g. 2.111(2) vs.
2.201(2) in 1]. The bond distances of Mo–O (water) [2.145(3)
and 2.130(3) Å for 1 and 2.152(4) and 2.160(4) Å for 2] and Mo–
Oox [2.159av Å for 1 and 2.169av Å for 2, 2.174av Å for 3 and




An incomplete cubane cluster anion [Mo3O4(ox)3(im)3]
2− in
5 is joined by imidazole and oxalate to complete a circular
species in Fig. 1 (right). Each Mo atom in 5 is surrounded octa-
hedrally by two μ2-O, one μ3-O, one N atom of imidazole ligand
and two carboxy O atoms in oxalato ligand. The three imida-
zole ligands occupy a cis position to the μ2-O. The observed
Mo–Mo distance (2.4939av Å) is close to the other reported
[Mo3O4]
4+ units, while shorter than those of [Mo3S4]
4+
cores.11b,13 Recently reported Mo3O4 cluster in Mo storage
Scheme 1 Syntheses and transformations of imidazole oxalato molybdenum species in different oxidation states.
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protein presented a similar incomplete cubane anion as that
in 5. Each Mo atom is octahedrally coordinated to five O atoms
and to the imidazole Nε2 atom of hisα140.11d Unfortunately, no
crystal data are available for further comparison. An overlay of
Mo3 unit in 5 and that in Mo storage protein was shown in
Fig. 2.
Single crystal X-ray diffraction analysis reveals that com-
plexes 6 and 7 are neutral trinuclear molybdenum compounds
[Fig. 3 and S4†]. There is a solvated imidazole molecule in 6.
Based on the rule of bond valence sum (BVS), oxidation states
of molybdenum atoms are calculated with a linear corre-
lation.14 The bond valence sums are 4.966, 5.892 and 5.077 for
6, and 5.001, 5.877 and 4.981 for 7 respectively as shown in
Table 2. Those in 1–5 are in normal ranges with molybdenum
(VI), (V) and (IV). It is interesting to note that the calculated oxi-
dation state (3.318) in FeMo-co is between molybdenum(III)
and (IV), which is in agreement with those reported.17
A previous report showed dinuclear imidazole molybdenum
complex as [Mo6+2O6(im)4] species with oxidation state of +6,
15
where two oxygen atoms were disordered over two positions.
However, the calculated BVS values for both molybdenum
atoms are 4.998, which show the oxidation states are +5 for the
Mo atoms (Table 2). Moreover, the long bond distances for
terminal MovO bond [1.848(2) Å] are out of the reported
range.3 A chemical formula of [Mo2O4(im)4(OH)2] is suggested
for this species.
Owing to the partially reduced molybdenum(V) atoms, the
structure of [Mo3O8(im)4] in 6 and 7 shows a novel feature.
Each [MoV2O4]
2+ ion is coordinated by one [MoVIO4]
2− anion
and four imidazole ligands. The unreduced Mo6+ atom is coor-
dinated by four terminal oxo ligands, while the reduced Mo5+
atoms are hepta-coordinated, which are different from the
unreduced octanuclear species 8 in Fig. S5.† Bond distances in
6 and 7 are almost identical. The bonds in the MoO4 moiety
are much stronger than those link to Mo2O4 moiety, which can
be explained by the impressive difference of bond valence
around O2 and O5 (1.383 vs. 0.448 vu and 1.372 vs. 0.414 vu)
(vu = valence unit) (Table S3†). The Mo–Mo bond [2.5731(6) Å
for 6 and 7] between two reduced Mo(V) atoms is in agreement
with the reported range.18
Fig. 1 Perspective views of the anion structures in cis-Na2[Mo2O4(ox)2(im)2]·4.5H2O (3) (left) and K(Him)[Mo3O4(ox)3(im)3]·3H2O (5) (right), thermal ellipsoids are
drawn by Ortep and represent in 30% probability surfaces.
Fig. 2 Comparison of the Mo–oxalato–im unit in 5 with Mo3O10(his) in Mo
storage protein (MoSto) from Azotobacter vinelandii (PDB 4F6T). Front: Mo–
oxalato–im unit in 5; behind: Mo3O10(his).
Fig. 3 Perspective view of the neutral molecular structure in [Mo3O8(im)4]-
(im)·H2O (6), thermal ellipsoids are drawn by Ortep and represented in 30%
probability surfaces.
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It is difficult to predict the structure of mixed-valence mol-






could be served as a smaller building unit. In addition, the
bond distances of uncoordinated oxo groups in Mo6+O4 unit
are shorter than those linked to [MoV2O4]
2+ based mixed-
valence complexes (Table 3), such as [Mo4O8(tdci)
(MoO4)2]·≈27H2O, [Mo3O8(bpy)2]n and (C4H12N2)2n[(MoV2O4)
(MoVIO4)(ox)2]n·2nH2O.
20
Hydrogen bonds of imidazoles play important roles in the
crystal packing of the structures 1–8 (Table S4†). Not only free
imidazole but also imidazole ligand can act as providers for
the two types of hydrogen bonds as N–H⋯O and N–H⋯N. N–
H⋯O interactions, which are found in imidazole with bridging
or terminal oxo atoms, and oxygen atoms from oxalate or
water molecules. N–H⋯N type of hydrogen bond is only
observed in compound 8. 3D crystal packing of 2 is connected
through the hydrogen bonds between imidazolium cations
and [Mo2O4(ox)2(H2O)2]
2− unit as shown in Fig. S6.† In 8, each
discrete [Mo8O26(im)2]
4− cluster is connected to the two adja-
cent clusters by N–H⋯O hydrogen bonds between coordinated
imidazole ligands and terminal oxo atoms, leading to 1D
supramolecular chain. With the help of hydrogen bonds by
imidazolium cations, the 3D supramolecular structure of 8 is
built (Fig. S7 and S8†).
The Mo–Nim, Mo–O(carboxy) and Mo–Mo distances in 1–8
vary systematically as shown in Table 4. It is concluded that
oxidation state of molybdenum atom has less influence on the
bond distance of Mo–Nim. The Mo–Mo bond distances in 1–8
decrease with the decrease of the oxidation state of molyb-
denum. The Mo–Nim distances in mixed-ligand molybdenum
compounds 3–5 seems not to be influenced by the oxidation
Table 2 Bond valence sum calculations for molybdenum complexes
Mon+ Compounds Mo1 Mo2 Mo3 Mo4 Ref.
+6 (Him)4[Mo8O26(im)2] (8) 5.994 5.998 6.034 6.014
+6/+5 [Mo3O8(im)4](im)·H2O (6) 4.966 5.892 5.077
[Mo3O8(im)4]·H2O (7) 5.001 5.877 4.981
+5 trans-Na(Him)[Mo2O4(ox)2(H2O)2]·H2O (1) 4.858 4.836 This work
trans-(Him)2[Mo2O4(ox)2(H2O)2] (2) 4.821 4.852
cis-Na2[Mo2O4(ox)2(im)2]·4.5H2O (3) 4.956 4.940
cis-K2[Mo2O4(ox)2(im)2]·3H2O (4) 4.952 4.944
[Mo2O6(im)4(OH)2] 4.998 15
+4 K(Him)[Mo3O4(ox)3(im)3]·3H2O (5) 4.005 3.997 3.928 This work
[MoFe7S9C(R-homocit)] 3.318 16










[Mo3O8(im)4](im)·H2O (6) (this work) 1.789 1.742









Table 4 Comparisons of Mo–Nim, Mo–O (carboxy) and Mo–Mo bond distances (Å) of molybdenum imidazole and oxalato complexes with FeMo-co {FeMo-co =
[MoFe7S9C(R-homocit)]} in nitrogenase
Mon+ Complexes M–Nim Mo–O(carboxy) Mo–Mo Ref.
+6 [Cu(im)2]4[(im)2Mo8O26]·4H2O 2.214(4) 2a
Mo8O26(glu)(his) MoSto Azotobacter vinelandii 2.14 2.11 11d
(Him)4[Mo8O26(im)2] (8) 2.218av This work
+6/+5 [Mo3O8(im)4](im)·H2O (6) 2.201av 2.5731(6)
[Mo3O8(im)4]·H2O (7) 2.203av 2.5731(6)
+5 trans-Na(Him)[Mo2O4(ox)2(H2O)2]·H2O (1) 2.159av 2.5568(4)
trans-(Him)2[Mo2O4(ox)2(H2O)2] (2) 2.165av 2.5547(4)
cis-Na2[Mo2O4(ox)2(im)2]·4.5H2O (3) 2.186av 2.174av 2.5597(5)
cis-K2[Mo2O4(ox)2(im)2]·3H2O (4) 2.187av 2.169av 2.5482(5)
+4 K(Him)[Mo3O4(ox)3(im)3]·3H2O (5) 2.184av 2.106av 2.4939av
MoO4(his) MoSto Azotobacter vinelandii 2.29 11d
+4/+3 [MoFe7S9C(R-homocit)] (PDB 3K1A) 2.46 2.17 21a
[MoFe7S9C(R-homocit)] (PDB 1QGU) 2.48(2)re, 2.47(2)ox 2.29(2)re, 2.29(2)ox 21b
[MoFe7S9C(R-homocit)] (PDB 3U7Q) 2.35 2.19 16
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state of molybdenum, while they are shorter than those of
higher-valence imidazole compounds 6–8. Mo–O (carboxy) dis-
tances of 1–4 are similar, indicating that coordinated imida-
zole has no obvious effect on oxalate ligands in 3 and 4. The
oxidation state of the molybdenum atom also shows less influ-
ence on the Mo–O (carboxy) distance.
The Mo–Nim distances in 1–8 are shorter than those of
FeMo-co (Table 4). The imidazole ligand in compounds 1–8
coordinated stronger than that of imidazole in the side chain
of histidine, resulting in a long Mo–Nim bond distance (2.35 Å)
in FeMo-co with 1.0 Å resolution.16 There are some agreements
in the coordination modes between Mo–oxalato–im units in 3
and 5 with Mo–homocitrate–histidine unit, which are shown
in Fig. 4 and S9,† where molybdenum atoms exhibit distorted
octahedral geometries. Mo–Nim distances (2.186 Å for 3 and
2.184 Å for 5) are shorter than that in FeMo-co. It seems the
shorter Mo–Nim distance (2.35 Å) is more suitable, like the
recent FeMo–protein structure with 1.0 Å resolution.16 Further-
more, bond distances of Mo–O (carboxy) (2.174 Å for 3 and
2.106 Å for 5) are close to that in FeMo-co, showing strong
coordination of carboxy group. Moreover, the study on com-
plexation between molybdenum with imidazole and α-hydroxy-
carboxylic acids such as glycolic, malic, citric and homocitric
acids is ongoing.
Vibrational spectra and UV spectra
IR spectra of 1–8 are listed in Fig. S10 and S11.† With the
bidentate oxalate, complexes 1–5 give three typical bands in
the regions of 1713–1665, 1409–1267 and 799–785 cm−1, which
correspond to asymmetric and symmetric carboxy, and δ(CO2)
vibrations respectively. The observed frequencies are
in agreement with the data observed for Ba[Mo2O4(η2-ox)2-
(H2O)2]·3H2O [1710–1653 cm
−1 for νas(CO2), 1430–1289 cm
−1
for νs(CO2) and 793 cm
−1 for δ(CO2)].
5 The frequencies of the
coordinated carboxylates shift to lower values compared to
those of the free ligands. The bands of 6 and 7 are almost
identical, which means that free solvated imidazole in 6 does
not cause the signal shift. The sharp bands around 950 cm−1
can be assigned to MovO vibrations for 1–8.
UV-Vis reflective spectra of 1–8 are given in Fig. S12 and
S13,† and their data are listed in Table S5.† The major bands
are around 205 nm for 1–8, and small bands around 260 and
230 nm for 1–4 and 6–8, respectively, which are assigned to
charge-transfer transitions for ligands to molybdenum ions.
Additionally, bands around 310 nm for 1–4, 6 and 7 are
assigned to the characteristic bands of [MoV2O4]
2+ core.22 The
band at 254 nm for 4 is attributed to its short Mo–Mo bond
(2.4939av Å).
NMR analyses
Solution 13C NMR spectra provide valuable information on the
coordination environments and chemical behaviors of 1–8,
which are shown in Fig. 5. The other solution 13C{1H} NMR
spectra are listed in Fig. S14–S22 and Table S6.† The observed
peaks for 1–8, sodium oxalate and imidazole are listed in
Table 5. NMR spectra of 5 cannot be recorded because of its
paramagnetic effect. Owing to the full dissociation on dissol-
ving in D2O (H2O), solution
13C NMR spectra of imidazole mol-
ybdenum complexes 6–8 show only one set of 13C highfield
resonances respectively as that of free ligand. However,
Fig. 4 Comparison of the partial Mo–oxalato–im unit in 5 with Mo–homoci-
trate–histidine coordinated unit in nitrogenase (PDB 3U7Q). Yellow–red: Mo–
oxalato–im unit; Green–blue: Mo–homocitrate–histidine unit.
Fig. 5 Solution 13C NMR spectra of 1–4 and 6–8.
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compounds 1–4 show one set of 13C NMR spectral signals in
downfield, which reveal they are stable in D2O (H2O). The coor-
dinated carboxy carbons are around 169 ppm, showing large
downfield shifts (Δδ = 3.08 ppm for 1) compared with that of
free oxalate. It is interesting that coordinated carboxy carbons
of oxalates in 1 and 2 give only one carbon signal, while those
give two carbon signals for 3 and 4. This may be explained by
the fact that two oxalate carbon atoms of coordinated oxalato
ligand in 3 and 4 are not chemically equivalent, owing to the
trans effect of the terminal oxo groups. Moreover, solution
NMR spectra of imidazolium cations in 1 and 2 show similar
patterns to that of free imidazole, which can serve as internal
references in the spectra.
Due to asymmetric coordination environments, imidazoles
in 3 and 4 appear as three major carbon signals in their sol-
ution 13C NMR spectra, compared with the two carbon signals
for free imidazole. This is because the coordination makes
uCH of imidazole split into two carbon signals. The 1H NMR
spectra of coordinated imidazole also exhibit three different
proton signals, which are consistent with their 13C NMR
spectra.
Solid 13C NMR spectra of 1, 3, 6 and 8 are shown in Fig. 6,
S23 and S24† for comparisons with their solution 13C NMR
spectra. The 13C NMR spectra reflect consistencies between
solid and solution states. For 1 and 3, the 13C resonances at
169.29 and 167.45, and 167.66 ppm are assigned to the
carboxy carbons for the coordinated oxalato ligand in 1 and 3
respectively. The resonances ranging from 140 to 120 ppm are
for the coordinated imidazoles. For imidazole molybdenum
complexes 6 and 8, their solvated and protonated imidazole
groups can serve as internal references. The fitting peaks at
140.66, 129.96, 115.17 ppm for 6 are assigned to coordinated
imidazole ligands, while the peaks centered at 137.39, 125.14,
119.92 ppm are attributed to solvated imidazoles. Highfield
shifts of imidazole are also found in the protonated imidazole
of 8.
There are two aspects of the imidazole and its mixed
oxalato molybdenum complexes in this report, namely, crystal-
line state chemistry as described by X-ray structural analysis
and supported by IR spectroscopy, and chemical behavior in
solution studied by solid and solution NMR spectroscopies.
The preparations of the complexes are carried out in aqueous
solutions wherein the product crystallization depends on the
solubility and concentration of products under particular con-
ditions. The former can only be guessed by structural analysis,
but the latter can be gauged from a 13C NMR tracing exper-
iment. In aqueous solution, Mo6+ and Mo6+/Mo5+ imidazole
complexes 6–8 decompose to free ligands. 13C NMR exper-
iments show ubiquitous decompositions in solution. However,
it is difficult to explain the solution stability for 1–4. Imida-
zoles mixed-ligand species are stable in solution, which may
be explained by the strong coordination of oxalate and for-
mation of hydrogen bond. For instant in 3, strong intermolecu-
lar hydrogen bonds are found between imidazole and oxalate
ligands [N(2)⋯O(9a) 2.907 Å, N(2)⋯O (O4b) 2.861 Å]
(Table S4†).
Cyclic voltammetry
Cyclic voltammograms of the reduced molybdenum com-
pounds scanning from −0.800 V to 1.000 V or 0.350 V were per-
formed in 1 mol L−1 Na2SO4 aqueous solution. Due to the
similar anion, only compounds 2, 4, 5 and 6 were investigated.
The cyclic voltammogram are shown in Fig. S25–S28† and the
corresponding electrochemical data are presented in
Table S7.† It was expected that the cyclic voltammogram of
both complexes 2 and 4 would show two or three reversible
redox series as in those of the other reported Mo2O4 species.
23
The investigation of complexes 2 and 4 display quasi-reversible
redox potentials at E1/2 = +0.238 and +0.113 V, respectively. The
difference of potential values between 2 and 4 suggests that
their behaviors of electron transfer are different.
Table 5 Solution 13C NMR spectral data (in ppm) of 1–4, 6–8, sodium oxalate
and imidazole
Compounds CO2α im
1 169.63 136.06, 121.57
2 168.85 136.10, 121.64
3 169.66, 168.20 141.08, 130.25, 120.84







1 169.29, 167.45 133.3, 117.64
3 167.66 140.30, 137.09, 125.01, 123.93,
120.22, 118.62
6 140.66, 129.96, 115.17
Solvent 137.39, 125.14,
119.92
8 140.43, 125.61, 115.47
Cation 132.44, 119.81 Fig. 6 Solid 13C NMR spectra of trans-Na(Him)[Mo2O4(ox)2(H2O)2]·H2O (1) and
cis-Na2[Mo2O4(ox)2(im)2]·4.5H2O (3).
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The previously reported cyclic voltammogram of
[Mo3O4(ox)3]
2− exhibited two well-separated reduction steps
and the magnitudes of the cathodic peak were supposed to be
consistent with a two-electron step followed by a one-electron
step.24 However, the cyclic voltammogram of 5 consists only a
single reduction and oxidation wave at E1/2 = +0.015 V, which
is similar to that of Mo3O4
4+.24 As for the cyclic voltammogram
of mixed-valence complex 6, there is a reductive wave at
around −0.343 V, which is much smaller than the oxidized
peak around +0.719 V, demonstrating unambiguously an irre-
versible process.
Conclusions
In summary, we have reported synthetic, spectral, structural,
redox process and bond valence calculations of mixed-ligand
molybdenum complexes of imidazole and oxalate in different
oxidation states. The complexes can be isolated under con-
trolled parameters in solution, such as pH value, molar ratio
of Mo : ligand and reducing agent, where imidazoles exist in
mixed-ligand, solvated, and cation forms. Trinuclear imidazole
mixed-valence molybdates 6 and 7 with unusual
[Mo2
5+O4(Mo
6+O4)] units may provide potential building block
for the further constructions of imidazole molybdenum com-
plexes. K(Him)[Mo3O4(ox)3(im)3]·3H2O (5) gives an interesting
example of mixed-ligand molybdenum(IV) complex. In
addition, NMR spectra of molybdates with oxalate and imida-
zole may offer a valuable clue for the substitution of imidazole
molybdates. The NMR spectra of imidazole molybdates 6–8
showed obvious decomposition in solution, while the mixed-
ligand complexes 3 and 4 are stable due to the coordination of
bidentate oxalate. However, the factors that affect stability in
solution are complex and also involve the stability of the
various solvated components relative to the stability of the
crystalline solid.
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